Gene · 3489
Papers1,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NR4A1 promotes LEF1 expression in the pathogenesis of papillary thyroid cancer. | Cell Death Discov | 2022 | 35110542 | PubTator, text mining | PubMed |
| The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats. | Arch Toxicol | 2022 | 35098321 | PubTator, text mining | PubMed |
| Proteome alterations in the aqueous humor reflect structural and functional phenotypes in patients with advanced normal-tension glaucoma. | Sci Rep | 2022 | 35075201 | PubTator, text mining | PubMed |
| Characterization of transcript enrichment and detection bias in single-nucleus RNA-seq for mapping of distinct human adipocyte lineages. | Genome Res | 2022 | 35042723 | PubTator, text mining | PubMed |
| Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. | Gut | 2022 | 35017197 | PubTator, text mining | PubMed |
| Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge. | Stem Cell Res Ther | 2022 | 35012669 | PubTator, text mining | PubMed |
| Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. | Genes Dis | 2022 | 35005108 | PubTator, text mining | PubMed |
| Reconstruction and Exploratory Analysis of mTORC1 Signaling Pathway and Its Applications to Various Diseases Using Network-Based Approach. | J Microbiol Biotechnol | 2022 | 35001007 | PubTator, text mining | PubMed |
| Insulin Growth Factor Phenotypes in Heart Failure With Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study. | J Card Fail | 2022 | 34979242 | PubTator, text mining | PubMed |
| Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer. | J Cancer | 2022 | 34976185 | PubTator, text mining | PubMed |
| Systems biology of angiogenesis signaling: Computational models and omics. | WIREs Mech Dis | 2022 | 34970866 | PubTator, text mining | PubMed |
| Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity. | Adipocyte | 2022 | 34964707 | PubTator, text mining | PubMed |
| Long-term in vivo survival of 3D-bioprinted human lipoaspirate-derived adipose tissue: proteomic signature and cellular content. | Adipocyte | 2022 | 34957918 | PubTator, text mining | PubMed |
| Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development. | Gastroenterology | 2022 | 34951993 | PubTator, text mining | PubMed |
| Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells. | Inflamm Bowel Dis | 2022 | 34918082 | PubTator, text mining | PubMed |
| A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumors. | Cancer Sci | 2022 | 34870878 | PubTator, text mining | PubMed |
| Mice with gene alterations in the GH and IGF family. | Pituitary | 2022 | 34797529 | PubTator, text mining | PubMed |
| Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia. | Mol Psychiatry | 2022 | 34741130 | PubTator, text mining | PubMed |
| Regenerative therapy for the Cornea. | Prog Retin Eye Res | 2022 | 34530154 | PubTator, text mining | PubMed |
| Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration. | Drug Test Anal | 2022 | 34418311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3489/papers?page=20